CAS 19395-41-6
:2-Piperidinacetat, α-phenyl-
- 2-(3,4-Dimethoxyphenyl)-3-Methylbutanenitrile
- 2-Phenyl-2-(2-Piperidine)Acetic Acid
- 2-Phenyl-2-(2-piperidyl)acetic acid
- 2-Phenyl-2-(Piperidin-2-Yl)Acetic Acid
- 2-Phenyl-2-piperidin-2-ylacetic acid
- 2-Piperidineacetic acid, α-phenyl-
- Phenly(2-piperidinyl)acetic acid
- Phenyl(2-piperidinyl)acetic acid
- Phenyl(Piperidin-2-Yl)Acetic Acid
- Rilatinic acid
- Ritalinic acid
- alpha-Phenylpiperidine-2-acetic acid
- Weitere Synonyme anzeigen
Ritalinic Acid
CAS:Formel:C13H17NO2Reinheit:>98.0%(T)(HPLC)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:219.28Phenyl(2-piperidinyl)acetic acid
CAS:Formel:C13H17NO2Reinheit:95%Farbe und Form:SolidMolekulargewicht:219.2796Ritalinic acid
CAS:Compound PDK0106, with CAS No. 19395-41-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0106 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.Formel:C13H17NO2Farbe und Form:Off-White SolidMolekulargewicht:219.27962-Phenyl-2-(piperidin-2-yl)acetic acid
CAS:Formel:C13H17NO2Reinheit:98%(HPLC);RGMolekulargewicht:219.2842-Phenyl-2-(2-piperidy)acetic acid
CAS:Kontrolliertes ProduktMethylphenidate is a psychostimulant drug used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is a prodrug of the active compound, 2-phenyl-2-(2-piperidin)acetic acid (Ritalinic acid), which inhibits the reuptake of dopamine and norepinephrine into the presynaptic neuron. Methylphenidate can be detected by LC-MS/MS in wastewater, providing an analytical method for predicting the presence of this substance in wastewater treatment plants. This drug has minimal toxicity in model organisms and can be metabolized by methylation to form a glucuronide conjugate. Methylphenidate has been shown to increase locomotor activity when administered at low doses, but not at high doses. At high doses, it increases locomotor activity up to 3 hours after administration and decreases locomotor activity 1 hour after administration.
Formel:C13H17NO2Reinheit:Min 98%Farbe und Form:White PowderMolekulargewicht:219.28 g/molRef: 3D-FP33840
Ausgelaufenes produkt






